T 1050/12 (Treatment of stress urinary incontinence/UNIVERSITY OF PITTSBURGH) of 22.01.2018
- European Case Law Identifier
- ECLI:EP:BA:2018:T105012.20180122
- Date of decision
- 22 January 2018
- Case number
- T 1050/12
- Petition for review of
- -
- Application number
- 05000057.9
- IPC class
- A61K 35/34A61P 13/02C12N 5/08
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Use of myoblasts in the manufacture of a medicament for treating stress urinary incontinence
- Applicant name
- UNIVERSITY OF PITTSBURGH
- Opponent name
- Innovacell Biotechnologie AG
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 112(1)(a)European Patent Convention Art 123(2)European Patent Convention Art 54(2)Rules of procedure of the Boards of Appeal Art 13
- Keywords
- Referral to the Enlarged Board of Appeal - (no)
Remittal to the department of first instance - (no)
Novelty - (no)
- meeting abstracts available to library users before priority date
- enabling disclosure for medical indication
Amendments - intermediate generalisation
Late-filed auxiliary requests - Catchword
- Meeting abstracts published in a supplement to a regular volume of a scientific journal found to be publicly available before the priority date of the patent on the basis of library date-stamps and accompanying declarations of the librarians (see Reasons 3.1 to 3.5).
- Citing cases
- -
Order
For these reasons it is decided that:
1. The appealed decision is set aside.
2. The patent is revoked.